Logo image of AEYE

AUDIOEYE INC (AEYE) Stock Fundamental Analysis

NASDAQ:AEYE - Nasdaq - US0507342014 - Common Stock - Currency: USD

12.61  +0.72 (+6.06%)

After market: 13.24 +0.63 (+5%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AEYE. AEYE was compared to 281 industry peers in the Software industry. Both the profitability and financial health of AEYE have multiple concerns. AEYE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AEYE had negative earnings in the past year.
In the past year AEYE had a positive cash flow from operations.
AEYE had negative earnings in each of the past 5 years.
In the past 5 years AEYE reported 4 times negative operating cash flow.
AEYE Yearly Net Income VS EBIT VS OCF VS FCFAEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.22%, AEYE is doing worse than 61.13% of the companies in the same industry.
The Return On Equity of AEYE (-44.87%) is worse than 67.49% of its industry peers.
Industry RankSector Rank
ROA -11.22%
ROE -44.87%
ROIC N/A
ROA(3y)-38.15%
ROA(5y)-47.93%
ROE(3y)-89.06%
ROE(5y)-172.85%
ROIC(3y)N/A
ROIC(5y)N/A
AEYE Yearly ROA, ROE, ROICAEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1K -2K -3K

1.3 Margins

AEYE has a better Gross Margin (78.87%) than 76.68% of its industry peers.
AEYE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AEYE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.14%
GM growth 5Y7.74%
AEYE Yearly Profit, Operating, Gross MarginsAEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

0

2. Health

2.1 Basic Checks

AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
AEYE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AEYE has been increased compared to 5 years ago.
AEYE has a worse debt/assets ratio than last year.
AEYE Yearly Shares OutstandingAEYE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
AEYE Yearly Total Debt VS Total AssetsAEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

AEYE has an Altman-Z score of 0.46. This is a bad value and indicates that AEYE is not financially healthy and even has some risk of bankruptcy.
AEYE's Altman-Z score of 0.46 is on the low side compared to the rest of the industry. AEYE is outperformed by 67.49% of its industry peers.
AEYE has a debt to FCF ratio of 8.98. This is a slightly negative value and a sign of low solvency as AEYE would need 8.98 years to pay back of all of its debts.
AEYE has a Debt to FCF ratio of 8.98. This is comparable to the rest of the industry: AEYE outperforms 49.47% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that AEYE has dependencies on debt financing.
With a Debt to Equity ratio value of 1.24, AEYE is not doing good in the industry: 78.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 8.98
Altman-Z 0.46
ROIC/WACCN/A
WACC13.77%
AEYE Yearly LT Debt VS Equity VS FCFAEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

AEYE has a Current Ratio of 0.84. This is a bad value and indicates that AEYE is not financially healthy enough and could expect problems in meeting its short term obligations.
AEYE has a worse Current ratio (0.84) than 79.86% of its industry peers.
AEYE has a Quick Ratio of 0.84. This is a bad value and indicates that AEYE is not financially healthy enough and could expect problems in meeting its short term obligations.
AEYE has a Quick ratio of 0.84. This is in the lower half of the industry: AEYE underperforms 79.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
AEYE Yearly Current Assets VS Current LiabilitesAEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

6

3. Growth

3.1 Past

AEYE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.45%, which is quite impressive.
Looking at the last year, AEYE shows a small growth in Revenue. The Revenue has grown by 6.92% in the last year.
Measured over the past years, AEYE shows a very strong growth in Revenue. The Revenue has been growing by 40.80% on average per year.
EPS 1Y (TTM)56.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y15.21%
Revenue growth 5Y40.8%
Sales Q2Q%13.87%

3.2 Future

Based on estimates for the next years, AEYE will show a very strong growth in Earnings Per Share. The EPS will grow by 32.17% on average per year.
Based on estimates for the next years, AEYE will show a quite strong growth in Revenue. The Revenue will grow by 17.52% on average per year.
EPS Next Y53.79%
EPS Next 2Y45.2%
EPS Next 3Y32.17%
EPS Next 5YN/A
Revenue Next Year12.27%
Revenue Next 2Y16.56%
Revenue Next 3Y17.52%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AEYE Yearly Revenue VS EstimatesAEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
AEYE Yearly EPS VS EstimatesAEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

AEYE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 237.75 indicates a quite expensive valuation of AEYE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AEYE indicates a slightly more expensive valuation: AEYE is more expensive than 60.78% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, AEYE is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 237.75
AEYE Price Earnings VS Forward Price EarningsAEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

AEYE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 150.87
EV/EBITDA N/A
AEYE Per share dataAEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as AEYE's earnings are expected to grow with 32.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.2%
EPS Next 3Y32.17%

0

5. Dividend

5.1 Amount

No dividends for AEYE!.
Industry RankSector Rank
Dividend Yield N/A

AUDIOEYE INC

NASDAQ:AEYE (3/7/2025, 8:03:46 PM)

After market: 13.24 +0.63 (+5%)

12.61

+0.72 (+6.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-12 2025-03-12/amc
Inst Owners39.55%
Inst Owner Change50.31%
Ins Owners32.45%
Ins Owner Change0.26%
Market Cap153.59M
Analysts82
Price Target33.35 (164.47%)
Short Float %10.62%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-1.75%
Max Revenue beat(2)-1.51%
Revenue beat(4)0
Avg Revenue beat(4)-1.78%
Min Revenue beat(4)-2.48%
Max Revenue beat(4)-1.38%
Revenue beat(8)0
Avg Revenue beat(8)-1.9%
Revenue beat(12)0
Avg Revenue beat(12)-1.66%
Revenue beat(16)0
Avg Revenue beat(16)-1.69%
PT rev (1m)0%
PT rev (3m)-5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-67.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 237.75
P/S 4.61
P/FCF 150.87
P/OCF 51.13
P/B 20.89
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)0.05
Fwd EY0.42%
FCF(TTM)0.08
FCFY0.66%
OCF(TTM)0.25
OCFY1.96%
SpS2.74
BVpS0.6
TBVpS-0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.22%
ROE -44.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.87%
FCFM 3.05%
ROA(3y)-38.15%
ROA(5y)-47.93%
ROE(3y)-89.06%
ROE(5y)-172.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.14%
GM growth 5Y7.74%
F-Score5
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 8.98
Debt/EBITDA N/A
Cap/Depr 84.08%
Cap/Sales 5.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 0.46
F-Score5
WACC13.77%
ROIC/WACCN/A
Cap/Depr(3y)91.08%
Cap/Depr(5y)91.73%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y53.79%
EPS Next 2Y45.2%
EPS Next 3Y32.17%
EPS Next 5YN/A
Revenue 1Y (TTM)6.92%
Revenue growth 3Y15.21%
Revenue growth 5Y40.8%
Sales Q2Q%13.87%
Revenue Next Year12.27%
Revenue Next 2Y16.56%
Revenue Next 3Y17.52%
Revenue Next 5YN/A
EBIT growth 1Y64.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year203.31%
EBIT Next 3Y53.25%
EBIT Next 5YN/A
FCF growth 1Y112.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.91%
OCF growth 3YN/A
OCF growth 5YN/A